These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. JAK-STAT signaling maintains homeostasis in T cells and macrophages. Fortelny N; Farlik M; Fife V; Gorki AD; Lassnig C; Maurer B; Meissl K; Dolezal M; Boccuni L; Ravi Sundar Jose Geetha A; Akagha MJ; Karjalainen A; Shoebridge S; Farhat A; Mann U; Jain R; Tikoo S; Zila N; Esser-Skala W; Krausgruber T; Sitnik K; Penz T; Hladik A; Suske T; Zahalka S; Senekowitsch M; Barreca D; Halbritter F; Macho-Maschler S; Weninger W; Neubauer HA; Moriggl R; Knapp S; Sexl V; Strobl B; Decker T; Müller M; Bock C Nat Immunol; 2024 May; 25(5):847-859. PubMed ID: 38658806 [TBL] [Abstract][Full Text] [Related]
63. EEG Information Transfer Changes in Different Daily Fatigue Levels During Drowsy Driving. Huang KC; Tseng CY; Lin CT IEEE Open J Eng Med Biol; 2024; 5():180-190. PubMed ID: 38606398 [TBL] [Abstract][Full Text] [Related]
64. Interferons and epigenetic mechanisms in training, priming and tolerance of monocytes and hematopoietic progenitors. Mishra B; Ivashkiv LB Immunol Rev; 2024 May; 323(1):257-275. PubMed ID: 38567833 [TBL] [Abstract][Full Text] [Related]
65. Histone deacetylase inhibitor boosts anticancer potential of fusogenic oncolytic vaccinia virus by enhancing cell-cell fusion. Nakatake M; Kurosaki H; Nakamura T Cancer Sci; 2024 Feb; 115(2):600-610. PubMed ID: 38037288 [TBL] [Abstract][Full Text] [Related]
66. ProLonged Liposomal Delivery of TLR7/8 Agonist for Enhanced Cancer Vaccine. Kim S; Park Y; Kim J; Kim S; Choi K; Kang T; Lee I; Lim YT; Um SH; Kim C Vaccines (Basel); 2023 Sep; 11(9):. PubMed ID: 37766179 [TBL] [Abstract][Full Text] [Related]
67. A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG. Miranda J; Vázquez-Blomquist D; Bringas R; Fernandez-de-Cossio J; Palenzuela D; Novoa LI; Bello-Rivero I BMC Cancer; 2023 Aug; 23(1):806. PubMed ID: 37644431 [TBL] [Abstract][Full Text] [Related]
68. Twist1-IRF9 Interaction Is Necessary for IFN-Stimulated Gene Anti-Zika Viral Infection. You Y; Grasso E; Alvero A; Condon J; Dimova T; Hu A; Ding J; Alexandrova M; Manchorova D; Dimitrova V; Liao A; Mor G J Immunol; 2023 Jun; 210(12):1899-1912. PubMed ID: 37144865 [TBL] [Abstract][Full Text] [Related]
69. M cell maturation and cDC activation determine the onset of adaptive immune priming in the neonatal Peyer's patch. Torow N; Li R; Hitch TCA; Mingels C; Al Bounny S; van Best N; Stange EL; Simons B; Maié T; Rüttger L; Gubbi NMKP; Abbott DA; Benabid A; Gadermayr M; Runge S; Treichel N; Merhof D; Rosshart SP; Jehmlich N; Hand TW; von Bergen M; Heymann F; Pabst O; Clavel T; Tacke F; Lelouard H; Costa IG; Hornef MW Immunity; 2023 Jun; 56(6):1220-1238.e7. PubMed ID: 37130522 [TBL] [Abstract][Full Text] [Related]
70. IFN regulatory factor 3 of golden pompano and its NLS domain are involved in antibacterial innate immunity and regulate the expression of type I interferon (IFNa3). Sun Y; Cao Z; Zhang P; Wei C; Li J; Wu Y; Zhou Y Front Immunol; 2023; 14():1128196. PubMed ID: 36817435 [TBL] [Abstract][Full Text] [Related]
72. Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG. Vázquez-Blomquist D; Hardy-Sosa A; Baez SC; Besada V; Palomares S; Guirola O; Ramos Y; Wiśniewski JR; González LJ; Bello-Rivero I Cells; 2022 Dec; 11(24):. PubMed ID: 36552831 [TBL] [Abstract][Full Text] [Related]
73. Emerging Roles of Type-I Interferons in Neuroinflammation, Neurological Diseases, and Long-Haul COVID. Tan PH; Ji J; Hsing CH; Tan R; Ji RR Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430870 [TBL] [Abstract][Full Text] [Related]
74. The transcription factor IRF2 drives interferon-mediated CD8 Lukhele S; Rabbo DA; Guo M; Shen J; Elsaesser HJ; Quevedo R; Carew M; Gadalla R; Snell LM; Mahesh L; Ciudad MT; Snow BE; You-Ten A; Haight J; Wakeham A; Ohashi PS; Mak TW; Cui W; McGaha TL; Brooks DG Immunity; 2022 Dec; 55(12):2369-2385.e10. PubMed ID: 36370712 [TBL] [Abstract][Full Text] [Related]
75. Individual and Synergistic Anti-Coronavirus Activities of SOCS1/3 Antagonist and Interferon α1 Peptides. Ahmed CM; Grams TR; Bloom DC; Johnson HM; Lewin AS Front Immunol; 2022; 13():902956. PubMed ID: 35799776 [TBL] [Abstract][Full Text] [Related]
76. Dysregulation of Type 1 Interferon Signaling in Systemic Sclerosis: a Promising Therapeutic Target? Wu M; Assassi S Curr Treatm Opt Rheumatol; 2021 Dec; 7(4):349-360. PubMed ID: 35694218 [TBL] [Abstract][Full Text] [Related]
77. Molecular and Clinical Investigation of COVID-19: From Pathogenesis and Immune Responses to Novel Diagnosis and Treatment. Kashani NR; Azadbakht J; Ehteram H; Kashani HH; Rajabi-Moghadam H; Ahmad E; Nikzad H; Hosseini ES Front Mol Biosci; 2022; 9():770775. PubMed ID: 35664675 [TBL] [Abstract][Full Text] [Related]
78. From bats to pangolins: new insights into species differences in the structure and function of the immune system. Haley PJ Innate Immun; 2022 Apr; 28(3-4):107-121. PubMed ID: 35506564 [TBL] [Abstract][Full Text] [Related]
79. Current understanding of the role of tyrosine kinase 2 signaling in immune responses. Muromoto R; Oritani K; Matsuda T World J Biol Chem; 2022 Jan; 13(1):1-14. PubMed ID: 35126866 [TBL] [Abstract][Full Text] [Related]
80. Single-cell transcriptional profiling of splenic fibroblasts reveals subset-specific innate immune signatures in homeostasis and during viral infection. Pezoldt J; Wiechers C; Erhard F; Rand U; Bulat T; Beckstette M; Brendolan A; Huehn J; Kalinke U; Mueller M; Strobl B; Deplancke B; Čičin-Šain L; Sitnik KM Commun Biol; 2021 Dec; 4(1):1355. PubMed ID: 34857864 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]